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Question:What is the effect of a multifactorial intervention on frailty and mobility in frail older people
who complywith their allocated treatment?Design: Secondary analysis of a randomised, controlled trial
to derive an estimate of complier average causal effect (CACE) of treatment. Participants: A total of
241 frail community-dwelling people aged  70 years. Intervention: Intervention participants received
a 12-month multidisciplinary intervention targeting frailty, with home exercise as an important
component. Control participants received usual care. Outcome measures: Primary outcomes were
frailty, assessed using the Cardiovascular Health Study criteria (range 0 to 5 criteria), and mobility
measured using the 12-point Short Physical Performance Battery. Outcomes were assessed 12 months
after randomisation. The treating physiotherapist evaluated the amount of treatment received on a 5-
point scale. Results: 216 participants (90%) completed the study. The median amount of treatment
received was 25 to 50% (range 0 to 100). The CACE (ie, the effect of treatment in participants compliant
with allocation) was to reduce frailty by 1.0 frailty criterion (95% CI 0.4 to 1.5) and increase mobility by
3.2 points (95% CI 1.8 to 4.6) at 12 months. The mean CACE was substantially larger than the intention-
to-treat effect, which was to reduce frailty by 0.4 frailty [22_TD$DIFF]criteria (95% CI 0.1 to 0.7) and increase mobility
by 1.4 points (95% CI 0.8 to 2.1) at 12 months. Conclusion: Overall, compliance was low in this group of
frail people. The effect of the treatment on participants who comply with allocated treatment was
substantially greater than the effect of allocation on all trial participants. Trial registration: Australian
and New Zealand Trial Registry ANZCTRN12608000250336. [Fairhall N, Sherrington C, Cameron ID,
Kurrle SE, Lord SR, Lockwood K, Herbert RD (2016) A multifactorial intervention for frail older
people is more than twice as effective among those who are compliant: complier average causal
effect analysis of a randomised trial. Journal of Physiotherapy 63: 40–44]
 2016 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The number and proportion of older people in the global
population are rapidly rising.1 [1_TD$DIFF] Frailty and mobility impairment
increase the risk of dependence, hospitalisation and death in older
people.2,3 Interventions that reduce frailty and improve mobility
have the potential to beneﬁt older people and society.4
The recommended primary approach to analysis of randomised,
controlled trials is analysis by intention to treat.5 Clinical trials in
frail older people are particularly affected by variable compliance
to treatment; some people randomised to the intervention group
will not undertake the intended treatment and some will
undertake part or all of the treatment.6 A range of statistical
techniques can provide estimates of the average causal treatment
effect among compliant participants.7,8 The framework and
assumptions of these techniques have been described in detailhttp://dx.doi.org/10.1016/j.jphys.2016.11.007
1836-9553/ 2016 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).elsewhere.8 Brieﬂy, we assume that at the start of a trial all
participants have an unobservable inherent trait that determines
whether or not they will comply with the allocated treatment. As
randomisation results in the expectation of an equal distribution of
compliers and non-compliers to the intervention and control
groups, we can observe the proportion of compliers and non-
compliers in the treatment group and infer the proportions in the
control group. Herein we use the term complier to describe a
participantwho undertakes treatment if allocated to the treatment
group and does not undertake treatment if allocated to the control
group. The term treatment received is used to describe the observed
amount of treatment undertaken by trial participants.
In our randomised, controlled trial of 241 frail older people, the
intention-to-treat analysis demonstrated that the multifactorial
intervention caused worthwhile improvements in frailty and
mobility, compared to usual care.9 The effect of actually.V. This is an open access article under the CC BY-NC-ND license (http://
Research 41undertaking the intervention in people who comply with their
allocated treatment, that is, the CACE, is of interest to those seeking
to implement such an intervention. Consequently we sought to
estimate the CACE. Previous studies that have estimated CACEs10–
12 have dichotomised compliance to prescribed treatment. As
compliance to an ongoing complex treatment is a continuous
quantity, analysis of compliance as a continuous or ordinal variable
may be preferable. We evaluated the CACE using instrumental
variable regression, with the amount of treatment received as a
continuous variable.8,13
Therefore, the research question for this secondary analysis of a
randomised, controlled trial was:
What is the effect of a multifactorial intervention on the
primary study outcomes of frailty and mobility in frail older
people who comply with their allocated treatment?
Method
Design
We conducted a secondary analysis of the Frailty Intervention
Trial – a prospective, parallel-group, assessor-blind, randomised,
controlled, single-centre trial. Participant recruitment commenced
in January 2008 and ﬁnished in June 2010. The protocol and
primary results have been published elsewhere.9,14–16
Participants
Brieﬂy, 241 participants were recruited following discharge
from the Division of Rehabilitation and Aged Care Services at
Hornsby Ku-ring-gai Health Service (Sydney, Australia). Eligible
participants: were aged 70 years; met the Cardiovascular Health
Study criteria for frailty (met speciﬁed cut-offs for three ormore of:
slow gait, weak grip, exhaustion, low energy expenditure and
weight loss);2 did not reside in a residential aged care facility; did
not have severe cognitive impairment (deﬁned as a Mini Mental
State Examination17 score of  18); and had a life expectancy
exceeding 12 months (estimated by a modiﬁed Implicit Illness
Severity Scale score of  3).18
The trial statistician developed the group allocation schedule
using a computer-generated, random number sequence that was
stratiﬁed by degree of frailty (three frailty criteria versus four or
ﬁve frailty criteria) using permuted blocks of random sizes. The
allocation schedulewas stored off-site and concealed from the staff
who recruited the trial participants. Following baseline assess-
ment, randomisation was performed by staff not involved in
recruitment or assessment. Researchers who collected outcome
measures, and recorded and analysed data were blinded to group
allocation. Participants and treating staff could not be blinded to
group allocation.
Intervention
Participants were randomised to receive usual care or a 12-
month interdisciplinary, multifactorial intervention. The treat-
ment, which has been described elsewhere,14was individualised to
each participant based upon the frailty criteria present and
incorporated the principles of geriatric evaluation and manage-
ment. Delivered by a team comprised of two physiotherapists, a
dietician, rehabilitation physician, geriatrician and nurse, the
treatment was coordinated by a physiotherapist and involved
case-conferences and case management. Participants who met the
weight-loss frailty criterion received dietician assessment and
management. All participants received 10 physiotherapy home
visits and a home exercise program consisting of lower limb
strength and balance exercises to be completed three to ﬁve times
per week for 12 months. Medical management included manage-
ment of chronic health conditions and medication review.Participants were referred to services as indicated. Multiple
strategies were used to maximise the amount of treatment
received by participants allocated to the treatment group, such
as involvement of family and carers, exercise diaries, visual cues,
goal setting, and education. The strategies are outlined using the
Behavior Change Technique Taxonomy19 in a supplementary ﬁle
(see Appendix 1).
The control group received the usual care provided to older
residents of the area from their general practitioner and
community services, which may have included medical and allied
health management, and assessment and delivery of care needs.
Outcome measures
The original trial had two primary outcomes: frailty and
mobility. Frailty was measured using a modiﬁcation of the
Cardiovascular Health Study deﬁnition of the frailty phenotype,
whereby frailty was deﬁned by the presence of at least three of ﬁve
criteria (weight loss, slow walking, weakness, exhaustion, low
energy expenditure).2,9 Mobility was measured with the Short
Physical Performance Battery,20 which measures: the ability to
stand for up to 10 seconds with feet side-by-side, semi-tandem
and tandem; time to walk 4 m; and time to rise from a chair ﬁve
times. Health professionals blinded to group allocation assessed
outcomes at baseline (before randomisation) and at 3 and
12 months after randomisation.
Measurement of treatment received
At weekly case conferences and each home visit, the
physiotherapist kept a written record of the treatment compo-
nents prescribed and treatment received by participants allocated
to the intervention group. Exercise intervention was measured by
number of repetitions as recorded in the participant’s exercise
diary, or where the physiotherapist considered the diary inaccu-
rate, estimated through discussion with the participant, their
family or carer plus assessment of physical progress. Self-report
and proxy-report was used to measure the number of dietician-
recommended supplements and meals taken. Follow-up of
medical conditions was measured by attendance at scheduled
appointments. Service use was quantiﬁed by the hours of services
accepted compared with the hours of services recommended by
the service provider or physiotherapist. At 12 months, the treating
physiotherapist calculated the overall amount of treatment
received as a proportion of the amount of treatment prescribed.
This estimate was reported on a 5-point scale that has face validity
and was determined prior to analysis of study outcomes: 0%, 1 to
25%, 26 to 50%, 51 to 75%, and 76 to 100%.
As the treatment was only deliverable to participants random-
ised to receive it, the amount of treatment received was only
measurable in the intervention group. It was assumed that the
control group could not access treatment.
Data analysis
The amount of treatment received was calculated for interven-
tion participants. We described baseline characteristics of the
intervention group participants by the amount of treatment
received, and reported the baseline characteristics of the control
group. The intention-to-treat effect was estimated as per the
original analysis; participants were analysed by group allocation,
irrespective of compliance, using linear regressionmodelswith the
baseline of the outcome as covariates.9 The CACE estimates the
mean effect of treatment in compliers who undertake 100% of
treatment if allocated to the treatment group and 0% of treatment if
allocated to the control group.13 We estimated the CACE using
instrumental variable regression13,21 using the ‘ivregress’ com-
mand in Stata softwarea with the two-stage least squares
estimator. The instrument was the randomly allocated treatment.
The amount of treatment received was entered as a continuous
[(Figure_1)TD$FIG]
Figure 1. Amount of treatment received in the intervention group. Number of
participants in each category is shown on the vertical axis (n = 120) and the amount
of treatment received on the horizontal axis.
Fairhall et al: Multifactorial intervention for frailty42variable. To enhance the precision of the estimate, we included
covariates that were signiﬁcantly associated with baseline frailty
in univariate regression analysis and likely to be related to amount
of treatment received: baseline age, use of a walking aid, mood,
cognition, and quality of life. The amount of treatment received
was plotted against change in frailty and change in mobility over
12 months in the intervention and control groups, with the spline
illustrating the relationship between amount of treatment and
outcome.22
Results
Flow of participants through the trial
Of the 241 randomised participants, 216 (90%) completed the
12-month assessment. The majority of losses to follow-up were
due to death (12 in the intervention group and 10 in the control
group). Three participants withdrew from the study (one from the
intervention group and two from the control group). One
participant in the intervention group hadmissing data for baseline
mood and cognition, andwas excluded from analyses that involved
these covariates.
There was no signiﬁcant association between loss to follow-up
and amount of treatment received. At the 12-month follow-up,
frailty and mobility data were available for 87% (60/69) of those
participants randomised to the intervention group who under-
took < 50% of treatment, and 92% (47/51) of the participants
randomised to the intervention group who undertook > 50% of
treatment (Chi-squared p-value = 0.37).
Themedian amount of treatment receivedwas 26 to 50% of that
prescribed. Sixteen (13%) of the 220 participants in the interven-
tion group received no intervention, 34 (29%) received 1 to 25% of
the intervention, 19 (16%) received 26 to 50%, 26 (21%) received
51 to 75%, and 25 (21%) received 76 to 100% (Figure 1).
Table 1 compares the baseline characteristics of the participants
in the control group and participants in each of the ﬁve categories
in the intervention group. There was little difference in the
characteristics of the groups, although participants randomised to
the intervention group who did not receive any treatment were
older and had poorer function measured using the SPPB and
Barthel Index.
Univariate regression analyses showed that age, walking aid,
mood and quality of life were independently and signiﬁcantly
(p < 0.05) associated with frailty; however, cognition was not. TheTable 1
Baseline characteristics of participants by amount of treatment received.
Characteristic Per
Control
(n=121)
0
(n=
Age (yr), mean (SD) 83.2 (5.9) 84.9
Gender, n male (%) 39 (32) 5 (
Lives alone, n (%) 51 (42) 8 (
Total frailty criteriaa, n (%)
3 79 (65) 9 (
4 30 (25) 7 (
5 12 (10) 0
Coexisting conditionsb, mean (SD) 5.9 (2.3) 5.8
Mini Mental State Examc,d, mean (SD) 25.9 (3.1) 25.4
Geriatric Depression Scalec,e, mean (SD) 5.1 (3.2) 4.8
Short Physical Performance Battery scoref, mean (SD) 5.7 (2.1) 4.4
Barthel Indexg, mean (SD) 92.5 (14.3) 89.1
Health-related quality of life, EQ-5Dh, mean (SD) 7.8 (1.5) 8.2
Data presented as number (%) or mean (standard deviation).
a Frailty Phenotype (modiﬁed from Cardiovascular Health Study criteria).
b Self-reported, doctor-diagnosed medical conditions.
c Missing data for Mini Mental Status Examination (n=2) and Geriatric Depression S
d The Mini Mental Status Examination17 has scores between 0 and 30, with higher s
e The Geriatric Depression Scale (short form)26 has scores between 0 and 15, with m
f The Short Physical Performance Battery20 has scores between 0 and 12, with a hig
g The Barthel Index27 has scores between 0 and 100, with higher scores indicating b
h The EQ-5D28 has scores between 5 and 15, with higher scores indicating worse hevariables independently and signiﬁcantly associated withmobility
were age, walking aid and quality of life, but not mood and
cognition. None of these variables were signiﬁcantly associated
with amount of treatment received on the 5-point scale.
Estimates of treatment effect
The estimates of the intention-to-treat effect and the CACE are
shown in Table 2. Including covariates in the analysis had little
effect on the results, so the unadjusted analyses are presented. The
CACE was a 1.0 criterion reduction in frailty (95% CI 0.4 to 1.5) and
3.2 point increase in mobility (95% CI 1.8 to 4.6) at 12 months. The
relationship between amount of treatment received and the frailty
and mobility outcomes are illustrated in Figures 2 and 3,
respectively.
The reduction in frailty was about 2.5 times greater with the
CACE estimate of treatment effect comparedwith the intention-to-
treat estimate (Table 2). Compared with intention to treat, the
CACE estimate of the treatment effect increased from 0.4 to 1.0 for
the reduction in frailty and from 1.4 to 3.2 for the improvement in
mobility. The signiﬁcance levels of the intention-to-treat and CACE
estimates were similar.centage of the multifactorial intervention received (n=120)
%
16)
1 to 25%
(n=34)
26 to 50%
(n=19)
51 to 75%
(n=26)
76 to 100%
(n=25)
(7.0) 83.6 (5.4) 83.6 (5.4) 83.0 (6.4) 82.6 (5.4)
31) 10 (29) 8 (42) 9 (35) 7 (28)
50) 18 (53) 8 (42) 12 (46) 14 (56)
56) 19 (56) 14 (74) 15 (58) 20 (80)
44) 13 (38) 3 (16) 8 (31) 2 (8)
(0) 2 (6) 2 (11) 3 (12) 3 (12)
(2.7) 6.3 (2.2) 6.5 (2.5) 5.2 (2.3) 5.5 (2.1)
(3.2) 27.1 (2.4) 26.4 (2.8) 26.5 (2.8) 27.1 (1.8)
(3.2) 4.8 (2.9) 4.8 (3.8) 5.3 (3.9) 4.1 (2.3)
(1.8) 4.9 (1.7) 5.3 (2.0) 5.7 (2.0) 5.6 (1.9)
(15.6) 93.7 (10.1) 94.5 (9.4) 93.5 (12.4) 97.4 (8.2)
(1.4) 7.7 (1.4) 7.5 (1.3) 7.6 (1.7) 7.4 (1.6)
cale (n=1).
core indicating better cognition.
ore depressive symptoms indicated by a higher score.
her score indicating better mobility.
etter basic activities of daily living functioning.
alth-related quality of life.
Table 2
Intention-to-treat and CACE estimates of treatment effect at 12 months.
Outcome Intention-to-treat estimatea CACE estimateb
Mean treatment
effect (95% CI)
p-value Mean treatment
effect (95% CI)
p-value
Frailtyc –0.4 (–0.1 to –0.7) 0.004 –1.0 (–0.4 to –1.5) 0.002
Mobilityd 1.4 (0.8 to 2.1) <0.001 3.2 (1.9 to 4.7) < 0.001
a Based on a linear regression model adjusted for baseline score.
b Based on an instrumental variable regression model, adjusted for baseline
score.
c Measured using modiﬁcation of Cardiovascular Health Study criteria2 (range
0 to 5).
d Measured using Short Physical Performance Battery20 (range 0 to 12).
CACE = complier average causal effect.
[(Figure_3)TD$FIG]
Figure 3. Amount of treatment received and change in mobility over 12 months in
intervention and control groups. Mobility was measured using the Short Physical
Performance Battery (range 0 to 12). Positive change indicates an increase in
[8_TD$DIFF]mobility. The symbol area is proportional to the number of participants. The line is a
median spline.
[(Figure_2)TD$FIG]
Figure 2. Amount of treatment received and change in frailty over 12 months in
intervention and control groups. Frailty was measured using modiﬁed
Cardiovascular Health Study Criteria (range 0 to 5). Negative change indicates a
reduction in frailty. The symbol area is proportional to the number of participants.
The line is a median spline.
Research 43Assuming a linear relationship between amount of treatment
received and the effect of the treatment on frailty, the size of the
effect on frailty is a reduction by 1.0 frailty criterion (95% CI 0.4 to
1.5) for a person who receives 100% of the intervention, 0.5 (95% CI
0.2 to 0.8) for a person who receives 50% of the intervention, and
0.2 (95% CI 0.1 to 0.4) for a person who receives 25% of the
intervention. The size of the effect on mobility is an increase of
3.2 points on the SPPB (95% CI 1.9 to 4.7) for a person who receives
100% of the intervention, 1.7 (95% CI 1.0 to 2.3) for a person who
receives 50% of the intervention, and 0.8 (95% CI 0.5 to 1.2) for a
person who receives 25% of the intervention.Discussion
To our knowledge this is the ﬁrst trial to examine the effect of an
intervention program targeting frailty on people who comply with
allocated intervention. Consideration of both the intention-to-
treat and CACE analyses provides a more complete understanding
of the effects of the intervention. It has been argued that CACE
estimates have greater clinical relevance and aremore indicative of
the effect of undertaking treatment.11 [7_TD$DIFF]
The method used to estimate the CACE is subject to
limitations. First, there is no established approach to identify
compliers and non-compliers to multifactorial interventions. We
estimated the amount of uptake of the intervention on a 5-point
scale; however, a performance-based method of quantifying
intervention would have been more precise. Second, although
access to the multifactorial intervention was limited to people
randomised to the intervention group, it is conceivable that the
treatment effect was underestimated because some participants
randomised to the control group undertook components of the
intervention.11 Third, a key assumption of CACE analysis is
exclusion restriction, which implies that the offer of treatment
affords no additional beneﬁt to non-compliers randomised to
the intervention group compared with non-compliers random-
ised to the control group.8 In this study there was potential for
placebo effects, which could have caused the exclusion
restriction to be violated and bias the CACE; however, such
placebo effects would bias both the intention-to-treat estimate
and the CACE estimate. Fourth, the two-stage least squares
approach to instrumental variable regression estimates the
‘weighted average of causal responses to a unit change in
treatment’.13 Thus, we have implicitly assumed that the effect of
intervention scales linearly with the proportion of the interven-
tion actually received. Finally, there were no data for the 22/241
participants who died (9%). The number of deaths was similar in
the intervention and control groups, so missingness due to death
was ignored in the analysis.
People who comply with allocated intervention experience a
clinically meaningful improvement in mobility and reduction in
frailty. The mean increase in mobility of 3.2 points on the SPPB
exceeded the suggested cut-off of 1.3 for a substantial, meaningful
change in a sample of older people with a higher level of
functioning,23 so is likely to be clinically signiﬁcant in this
comparatively frail group. The implications of reducing frailty by
one criterion are not yet clear, due to the limited research in this
area. However, this reduction is likely to bemeaningful to the older
person and those allocating healthcare resources, as it represents a
20% reduction in the 5-point Cardiovascular Health Study
criteria for frailty and participants, on average, beneﬁted by
being stronger, walking faster, being more active, not feeling
exhausted, or being better nourished. Cost-effectiveness analysis
previously showed that the intervention provided better value
for money than usual care, particularly for the very frail, in
whom it had a high likelihood of being cost saving and
effective.24
The amount of intervention undertaken was less than in most
trials of exercise interventions in frail older people.6,25 The
comparatively low uptake in this trial may be explained by the
multifaceted intervention and comparatively long 12-month
duration, during which frail older people are likely to experience
ﬂuctuating health, physical and social needs. Further studies are
needed to determine methods to increase uptake of interventions
among frail older people.
We previously estimated the effect of allocation to a
multifactorial intervention targeting frailty and concluded the
effect was clinically worthwhile. In this paper we estimated the
effect of the intervention in compliers and found a more than two-
fold greater effect of treatment in this group. It is recommended
that future studies of frail older people record and evaluate the
amount of treatment received and estimate effects of intervention
in compliant participants.
Fairhall et al: Multifactorial intervention for frailty44What was already known on this topic: Multifactorial
intervention can improve frailty and mobility in older people;
however, frail older people were poorly compliant with a
multifactorial intervention in a large controlled trial.
What this study adds: The data from the large trial were re-
analysed to determine the effect of the treatment among
participants who comply with whichever treatment they are
allocated. This re-analysis identified an effect of the interven-
tion that wasmore than two-fold greater than the effect among
all trial participants.Footnotes: a Stata version 13, College Station, USA.
eAddenda: Appendix 1 can be found online at doi:10.1016/j.
jphys.2016.11.007
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